Dexcom (DXCM) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.49% |
| Dec 31, 2025 | 11.43% |
| Sep 30, 2025 | 42.04% |
| Jun 30, 2025 | 16.85% |
| Mar 31, 2025 | 38.48% |
| Dec 31, 2024 | 12.16% |
| Sep 30, 2024 | 14.53% |
| Jun 30, 2024 | 64.70% |
| Mar 31, 2024 | 49.78% |
| Dec 31, 2023 | 38.35% |
| Sep 30, 2023 | 45.98% |
| Jun 30, 2023 | 33.38% |
| Mar 31, 2023 | 39.92% |
| Dec 31, 2022 | 23.93% |
| Sep 30, 2022 | 52.14% |
| Jun 30, 2022 | 104.02% |
| Mar 31, 2022 | -6.25% |
| Dec 31, 2021 | 51.39% |
| Sep 30, 2021 | 82.37% |
| Jun 30, 2021 | -43.69% |
| Mar 31, 2021 | -43.78% |
| Dec 31, 2020 | 227.14% |
| Sep 30, 2020 | 57.01% |
| Jun 30, 2020 | 56.86% |
| Mar 31, 2020 | -46.74% |
| Dec 31, 2019 | 92.17% |
| Sep 30, 2019 | 42.22% |
| Jun 30, 2019 | 51.57% |
| Mar 31, 2019 | -34.28% |
| Dec 31, 2018 | 50.10% |
| Sep 30, 2018 | 124.48% |
| Jun 30, 2018 | 97.79% |
| Mar 31, 2018 | -32.40% |
| Dec 31, 2017 | 31.73% |
| Sep 30, 2017 | 35.40% |
| Jun 30, 2017 | 17.61% |
| Mar 31, 2017 | -12.57% |
| Dec 31, 2016 | 22.20% |
| Sep 30, 2016 | 23.19% |
| Jun 30, 2016 | 35.72% |
| Mar 31, 2016 | -1.09% |
| Dec 31, 2015 | 54.77% |
| Sep 30, 2015 | 23.80% |